- Home
- LRMR vs SWIN Comparison
LRMR vs SWIN Comparison
Compare LRMR & SWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRMR
- SWIN
- Stock Information
- Founded
- LRMR N/A
- SWIN 2017
- Country
- LRMR United States
- SWIN Hong Kong
- Employees
- LRMR N/A
- SWIN N/A
- Industry
- LRMR Biotechnology: Pharmaceutical Preparations
- SWIN
- Sector
- LRMR Health Care
- SWIN
- Exchange
- LRMR Nasdaq
- SWIN Nasdaq
- Market Cap
- LRMR 309.8M
- SWIN 258.0M
- IPO Year
- LRMR N/A
- SWIN 2023
- Fundamental
- Price
- LRMR $3.96
- SWIN $2.70
- Analyst Decision
- LRMR Strong Buy
- SWIN
- Analyst Count
- LRMR 8
- SWIN 0
- Target Price
- LRMR $17.88
- SWIN N/A
- AVG Volume (30 Days)
- LRMR 1.3M
- SWIN 1.6M
- Earning Date
- LRMR 10-29-2025
- SWIN 06-30-2025
- Dividend Yield
- LRMR N/A
- SWIN N/A
- EPS Growth
- LRMR N/A
- SWIN N/A
- EPS
- LRMR N/A
- SWIN N/A
- Revenue
- LRMR N/A
- SWIN $3,316,000.00
- Revenue This Year
- LRMR N/A
- SWIN $29.79
- Revenue Next Year
- LRMR N/A
- SWIN $54.60
- P/E Ratio
- LRMR N/A
- SWIN N/A
- Revenue Growth
- LRMR N/A
- SWIN N/A
- 52 Week Low
- LRMR $1.61
- SWIN $1.16
- 52 Week High
- LRMR $9.50
- SWIN $5.09
- Technical
- Relative Strength Index (RSI)
- LRMR 54.10
- SWIN 37.82
- Support Level
- LRMR $3.78
- SWIN $2.60
- Resistance Level
- LRMR $4.26
- SWIN $3.04
- Average True Range (ATR)
- LRMR 0.27
- SWIN 0.47
- MACD
- LRMR -0.00
- SWIN -0.11
- Stochastic Oscillator
- LRMR 55.14
- SWIN 14.11
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About SWIN Solowin Holdings
Solowin Holdings Ltd is an investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secure one-stop electronic platform. It is engaged in providing securities-related services, investment advisory services, and asset management services to customers. The operations were organized into four reportable segments: Corporate Finance Services, Wealth Management Services, Asset Management Services and Virtual Assets. It derives maximum revenue from Wealth Management Services.